Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Firefly Neuroscience (AIFF) Long-Term Debt Issuances (2020 - 2023)

Firefly Neuroscience has reported Long-Term Debt Issuances over the past 4 years, most recently at $575000.0 for Q1 2023.

  • Quarterly results put Long-Term Debt Issuances at $575000.0 for Q1 2023, changed N/A from a year ago — trailing twelve months through Jun 2023 was $1.0 million (up 400.0% YoY), and the annual figure for FY2025 was $2.5 million, up 29.46%.
  • Long-Term Debt Issuances for Q1 2023 was $575000.0 at Firefly Neuroscience, up from $425000.0 in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for AIFF hit a ceiling of $597694.0 in Q3 2021 and a floor of -$450000.0 in Q3 2020.
  • Median Long-Term Debt Issuances over the past 4 years was $437500.0 (2020), compared with a mean of $200288.2.
  • Peak annual rise in Long-Term Debt Issuances hit 232.82% in 2021, while the deepest fall reached 188.38% in 2021.
  • Firefly Neuroscience's Long-Term Debt Issuances stood at $450000.0 in 2020, then crashed by 188.38% to -$397694.0 in 2021, then surged by 206.87% to $425000.0 in 2022, then surged by 35.29% to $575000.0 in 2023.
  • The last three reported values for Long-Term Debt Issuances were $575000.0 (Q1 2023), $425000.0 (Q4 2022), and -$397694.0 (Q4 2021) per Business Quant data.